Educational Panel : Advances in Dermatology: Recent Approvals and Later-Stage Trials

feb 12, 2018: 4 p.m. - 4:55 p.m.
Salon 4

2017 produced seven FDA approvals for new dermatology medicines, the most since 2014.  Additionally, several treatments in late-stage clinical development suggest opportunities for new help for patients suffering from some chronic and acute skin ailments.  This session will examine some of the exciting clinical results illuminating biological understanding of dermatological diseases and the emerging opportunities for investors in this space.


Moderator: Umer Raffat, Senior Managing Director, Evercore ISI


Michael Derby, Founder and Chief Executive Officer, Castle Creek Pharmaceuticals, LLC

Luis Peña, Founder & Chief Development Officer, Dermira, Inc.

Michael Sierra, PhD, Vice President, LEO Science & Tech Hub


Michael Derby
Founder and Chief Exec...

Luis Peña
Found and Chief Develo...

Michael Sierra, PhD
Vice President

Umer Raffat
Senior Managing Director